Lymphocyte depleted Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma characterized by a predominance of Reed-Sternberg cells and a scarcity of lymphocytes. It primarily affects the intrathoracic lymph nodes, leading to significant clinical implications such as respiratory distress and systemic symptoms. Accurate coding with ICD-10 Code C81.32 is essential for precise diagnosis, effective documentation, appropriate medical billing, and comprehensive public health reporting.
ICD-10 Code C81.32 specifically denotes lymphocyte depleted Hodgkin lymphoma affecting the intrathoracic lymph nodes. This condition is marked by a reduced number of lymphocytes and is associated with aggressive clinical behavior. The code should be utilized in clinical documentation and billing when diagnosing patients with this specific subtype of Hodgkin lymphoma, ensuring accurate representation of the patient's condition.
Lymphocyte depleted Hodgkin lymphoma is a rare and aggressive form of Hodgkin lymphoma that typically presents with significant lymph node involvement, particularly in the intrathoracic region. The etiology is not fully understood, but it is associated with immunosuppression and may progress rapidly, necessitating prompt medical intervention.
ICD-10 Code C81.32 plays a crucial role in SOAP notes by providing a clear diagnosis that guides clinical assessment and treatment planning. It is essential for documenting patient symptoms, evaluating disease progression, and formulating treatment strategies in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C81.32 connects subjective patient reports and objective clinical findings to a formal diagnosis of lymphocyte depleted Hodgkin lymphoma. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
Lymphocyte depleted Hodgkin lymphoma requires urgent medical attention due to its aggressive nature. Treatment typically involves chemotherapy and may include radiation therapy depending on the stage of the disease.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.32 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C81.32 for Lymphocy depleted Hodgkin lymphoma, intrathorac nodes
What are the common symptoms of lymphocyte depleted Hodgkin lymphoma?
Common symptoms include persistent cough, shortness of breath, unexplained weight loss, fever, night sweats, and fatigue. These symptoms often indicate advanced disease and require prompt medical evaluation.
How is lymphocyte depleted Hodgkin lymphoma diagnosed?
Diagnosis typically involves a combination of imaging studies, such as CT scans, and biopsy of affected lymph nodes to identify Reed-Sternberg cells. Laboratory tests may also be conducted to assess overall health.
What treatment options are available for lymphocyte depleted Hodgkin lymphoma?
Treatment usually involves chemotherapy, often in combination with radiation therapy, depending on the stage of the disease. Supportive care is also essential to manage symptoms and improve quality of life.
Is lymphocyte depleted Hodgkin lymphoma contagious?
No, lymphocyte depleted Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and is not transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes